What are the recommended drops for treating conjunctivitis in an adult patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Adult Conjunctivitis

For bacterial conjunctivitis in adults, use topical moxifloxacin 0.5% three times daily for 7 days as first-line therapy, while viral conjunctivitis requires only supportive care with artificial tears and cold compresses, and allergic conjunctivitis responds best to topical antihistamines with mast-cell stabilizing properties. 1, 2

Determining the Etiology

The treatment depends entirely on identifying whether the conjunctivitis is bacterial, viral, or allergic 1:

Bacterial conjunctivitis characteristics:

  • Mucopurulent or purulent discharge with eyelids matted shut upon waking 3, 4
  • Lack of itching 4
  • May be unilateral or bilateral 1
  • More common in children but occurs in adults 3

Viral conjunctivitis characteristics:

  • Watery discharge 3
  • Follicular reaction on conjunctiva 1
  • Preauricular lymphadenopathy 1
  • More common in adults 3

Allergic conjunctivitis characteristics:

  • Severe itching is the hallmark symptom 5, 4
  • Watery or mucoid discharge 6
  • Bilateral presentation 6
  • History of allergen exposure 7

Treatment by Etiology

Mild to Moderate Bacterial Conjunctivitis

First-line treatment:

  • Moxifloxacin 0.5% ophthalmic solution: one drop three times daily for 7 days 2
  • Provides superior gram-positive coverage including activity against some MRSA strains 1
  • Achieves 81% complete resolution at 48 hours and 84-94% microbiological eradication 1

Alternative options if moxifloxacin unavailable:

  • Ofloxacin 0.3%: one to two drops four times daily for 5-7 days 8
  • Other fluoroquinolones (levofloxacin, gatifloxacin, ciprofloxacin, besifloxacin) 1
  • No single antibiotic demonstrates superiority, so choice can be based on cost and convenience 5, 1

Important considerations:

  • Mild bacterial conjunctivitis is self-limited and resolves spontaneously in immunocompetent adults without treatment 5
  • Topical antibiotics provide earlier clinical remission (days 2-5) and allow faster return to work 5, 1
  • Povidone-iodine 1.25% ophthalmic solution may be as effective as antibiotics when access is limited 5

Severe Bacterial Conjunctivitis

Characterized by:

  • Copious purulent discharge 5
  • Marked pain and inflammation 5
  • Possible corneal involvement 1

Management approach:

  • Obtain conjunctival cultures and Gram staining before treatment if gonococcal infection suspected 5, 1
  • Consider MRSA, especially in nursing home residents or those with community-acquired infections 5
  • If unresponsive to moxifloxacin within 48-72 hours, consider compounded topical vancomycin for suspected MRSA 1

Gonococcal conjunctivitis requires:

  • Systemic antibiotics: ceftriaxone 250 mg IM single dose PLUS azithromycin 1 g oral single dose 1
  • Daily monitoring until resolution 1
  • Immediate ophthalmology referral 1

Chlamydial conjunctivitis requires:

  • Systemic antibiotics: azithromycin 1 g oral single dose OR doxycycline 100 mg oral twice daily for 7 days 1
  • Screen for concurrent genital infections and treat sexual partners 1

Viral Conjunctivitis

Adenoviral conjunctivitis (most common):

  • No proven effective antiviral treatment exists 1
  • Supportive care only: refrigerated preservative-free artificial tears four times daily and cold compresses 1
  • Avoid topical antibiotics due to potential adverse effects and resistance 1
  • Strict hand hygiene with soap and water to prevent transmission 1

Topical corticosteroids may be considered ONLY in severe cases with:

  • Marked chemosis 5, 1
  • Severe lid swelling 5, 1
  • Epithelial sloughing 5, 1
  • Membranous conjunctivitis 5, 1
  • Requires close monitoring for elevated intraocular pressure and cataract 5, 1

Herpes Simplex Virus (HSV) conjunctivitis:

  • Topical ganciclovir 0.15% gel three to five times daily OR trifluridine 1% solution five to eight times daily 1
  • Add oral antivirals (acyclovir, valacyclovir, or famciclovir) 1
  • NEVER use topical corticosteroids in HSV without antiviral coverage—they potentiate viral replication and worsen infection 1

Varicella Zoster Virus (VZV) conjunctivitis:

  • Oral antivirals: acyclovir 800 mg five times daily for 7 days, valacyclovir 1000 mg every 8 hours for 7 days, or famciclovir 500 mg three times daily for 7 days 5
  • Topical antibiotics may be used to prevent secondary bacterial infection from vesicle necrosis 5
  • Topical antivirals alone are not helpful 5

Allergic Conjunctivitis

First-line treatment:

  • Second-generation topical antihistamines with mast-cell stabilizing properties 5, 1
  • Examples include olopatadine, ketotifen, azelastine 5
  • Adjunctive measures: cold compresses, refrigerated preservative-free artificial tears, sunglasses as allergen barrier 1

Second-line treatment for persistent symptoms:

  • Brief 1-2 week course of low side-effect profile topical corticosteroids (fluorometholone, rimexolone, or loteprednol) 5, 1
  • Monitor intraocular pressure and evaluate for cataract if corticosteroids used 5

Severe or refractory cases:

  • Topical cyclosporine 0.05% at least four times daily 5
  • Cyclosporine 0.1% is FDA-approved specifically for vernal keratoconjunctivitis 5
  • Topical tacrolimus 0.03% or 0.1% for cases refractory to other treatments 5

Avoid:

  • Chronic use of topical vasoconstrictors—they cause rebound hyperemia 1
  • Oral antihistamines may worsen dry eye and exacerbate allergic conjunctivitis 1

Critical Red Flags Requiring Immediate Ophthalmology Referral

  • Visual loss or decreased vision 1, 3
  • Moderate to severe pain 1, 3
  • Severe purulent discharge suggesting gonococcal infection 1, 3
  • Corneal involvement (infiltrate, ulcer, opacity, scarring) 1, 3
  • Conjunctival scarring 1
  • Lack of response to therapy after 3-4 days 1
  • Recurrent episodes 1
  • History of HSV eye disease 1, 3
  • Immunocompromised state 1, 3
  • Recent ocular surgery 3
  • Vesicular rash on eyelids or nose 3

Common Pitfalls to Avoid

  • Never use topical corticosteroids in HSV conjunctivitis without antiviral coverage—this potentiates infection and can cause corneal perforation 1
  • Do not use preserved artificial tears more than 4 times daily—preservatives cause ocular surface toxicity 9
  • Avoid indiscriminate antibiotic use in viral conjunctivitis—antibiotics induce toxicity and promote resistance 1
  • Do not assume copious discharge always means bacterial infection—severe adenoviral conjunctivitis can present similarly 1
  • Delayed referral for gonococcal conjunctivitis leads to poor outcomes including corneal perforation and vision loss 1
  • Failure to consider sexual abuse in adults with gonococcal or chlamydial conjunctivitis can have serious consequences 1
  • Prolonged topical trifluridine use (>2 weeks) causes epithelial toxicity 1

Follow-Up Strategy

  • Re-evaluate in 3-4 days if no improvement with bacterial conjunctivitis treatment 1, 10
  • Gonococcal conjunctivitis requires daily visits until resolution 1
  • If using topical corticosteroids, measure intraocular pressure periodically and perform pupillary dilation to evaluate for cataract 5, 1
  • Counsel patients about contagious varieties to prevent spread, emphasizing handwashing and avoiding close contact for 7-14 days in viral conjunctivitis 1

References

Guideline

Conjunctivitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Conjunctivitis: Diagnosis and Management.

American family physician, 2024

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Conjunctivitis: A Systematic Review.

Journal of ophthalmic & vision research, 2020

Research

Conjunctivitis.

American family physician, 1998

Guideline

Treatment of Persistent Chronic Eye Watering Without Itchiness

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Bacterial Conjunctivitis in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.